JLABS @ TORONTO: Growing & Building an Early-Stage A.I. Venture in Life Sciences

'The A.I. In Life Sciences Market is estimated to be worth USD 2.88 billion in 2024, projected to reach USD 8.88 billion by 2029, with a growth rate of 25.23% during the forecast period (2024-2029).'*

On May 14th, in partnership with Nucleate Canada, JLABS @ Toronto will bring together industry leaders, founders, investors, and academics, in the A.I. in Life sciences field to discuss the latest insights and strategies for early-stage A.I. ventures in life sciences.

The panel discussion will cover:

- Navigating the startup landscape as an A.I. venture
- Opportunities and challenges of A.I. life sciences companies
- Leveraging A.I. for drug discovery and development, A.I.-driven precision medicine, and advancements in A.I.-powered diagnostics.

Don't miss out on this opportunity to connect with like-minded individuals and gain valuable insights into this rapidly evolving field.

Register now to secure your spot!

*Source: https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-life-sciences-market.